Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer
A maximum of 8 cycles of chemotherapy will be administered. Depending on patients' tolerability, 8 cycles of chemotherapy will be given to the patients.
Stage IV Gastric Cancer With Metastasis
OTHER: Docetaxel
Maximum tolerated dose, Phase I Study

- Maximum tolerated dose of Intraperitoneal Docetaxel

Phase II Study

* Progression-free survival rate at 6 months
* response rate, time to progression, overall survival, 1 year
Safety profile, 1 year|Overall survival, 1 year|Progression free survival, 1 year|efficacy, 1 year
Single-center, open-label, prospective, single-arm, phase I-II study

About 37 patients (Phase I 18, Phase II 31 (including 12 patients from Phase I)